Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar across multiple seasons and in diverse populations is unknown. We applied systems approaches to study immune responses in young, elderly, and di...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Immunity (Cambridge, Mass.) Ročník 43; číslo 6; s. 1186 - 1198
Hlavní autori: Nakaya, Helder I, Hagan, Thomas, Duraisingham, Sai S, Lee, Eva K, Kwissa, Marcin, Rouphael, Nadine, Frasca, Daniela, Gersten, Merril, Mehta, Aneesh K, Gaujoux, Renaud, Li, Gui-Mei, Gupta, Shakti, Ahmed, Rafi, Mulligan, Mark J, Shen-Orr, Shai, Blomberg, Bonnie B, Subramaniam, Shankar, Pulendran, Bali
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 15.12.2015
Predmet:
ISSN:1097-4180
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar across multiple seasons and in diverse populations is unknown. We applied systems approaches to study immune responses in young, elderly, and diabetic subjects vaccinated with the seasonal influenza vaccine across five consecutive seasons. Signatures of innate immunity and plasmablasts correlated with and predicted influenza antibody titers at 1 month after vaccination with >80% accuracy across multiple seasons but were not associated with the longevity of the response. Baseline signatures of lymphocyte and monocyte inflammation were positively and negatively correlated, respectively, with antibody responses at 1 month. Finally, integrative analysis of microRNAs and transcriptomic profiling revealed potential regulators of vaccine immunity. These results identify shared vaccine-induced signatures across multiple seasons and in diverse populations and might help guide the development of next-generation vaccines that provide persistent immunity against influenza.
AbstractList Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar across multiple seasons and in diverse populations is unknown. We applied systems approaches to study immune responses in young, elderly, and diabetic subjects vaccinated with the seasonal influenza vaccine across five consecutive seasons. Signatures of innate immunity and plasmablasts correlated with and predicted influenza antibody titers at 1 month after vaccination with >80% accuracy across multiple seasons but were not associated with the longevity of the response. Baseline signatures of lymphocyte and monocyte inflammation were positively and negatively correlated, respectively, with antibody responses at 1 month. Finally, integrative analysis of microRNAs and transcriptomic profiling revealed potential regulators of vaccine immunity. These results identify shared vaccine-induced signatures across multiple seasons and in diverse populations and might help guide the development of next-generation vaccines that provide persistent immunity against influenza.
Author Shen-Orr, Shai
Duraisingham, Sai S
Gaujoux, Renaud
Frasca, Daniela
Ahmed, Rafi
Gersten, Merril
Li, Gui-Mei
Rouphael, Nadine
Subramaniam, Shankar
Pulendran, Bali
Nakaya, Helder I
Lee, Eva K
Kwissa, Marcin
Blomberg, Bonnie B
Mehta, Aneesh K
Gupta, Shakti
Mulligan, Mark J
Hagan, Thomas
Author_xml – sequence: 1
  givenname: Helder I
  surname: Nakaya
  fullname: Nakaya, Helder I
  organization: School of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 580, São Paulo 05508, Brazil; Department of Pathology, School of Medicine, Emory University, 1648 Pierce Drive NE, Atlanta, GA 30307, USA
– sequence: 2
  givenname: Thomas
  surname: Hagan
  fullname: Hagan, Thomas
  organization: Department of Bioengineering, University of California, 9500 Gilman Drive MC 0412, San Diego, La Jolla, CA 92093, USA
– sequence: 3
  givenname: Sai S
  surname: Duraisingham
  fullname: Duraisingham, Sai S
  organization: Department of Immunology, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford OX3 7J, UK
– sequence: 4
  givenname: Eva K
  surname: Lee
  fullname: Lee, Eva K
  organization: Center for Operations Research in Medicine & Healthcare, School of Industrial & Systems Engineering, Georgia Institute of Technology, North Avenue NW, Atlanta, GA 30332, USA
– sequence: 5
  givenname: Marcin
  surname: Kwissa
  fullname: Kwissa, Marcin
  organization: Institute for Molecular Engineering, University of Chicago, 5640 S. Elis Avenue, Chicago, IL 60637, USA
– sequence: 6
  givenname: Nadine
  surname: Rouphael
  fullname: Rouphael, Nadine
  organization: Hope Clinic of Emory University, 500 Irvin Court/Suite 200, Atlanta, GA 30030, USA
– sequence: 7
  givenname: Daniela
  surname: Frasca
  fullname: Frasca, Daniela
  organization: Department of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL 33136, USA
– sequence: 8
  givenname: Merril
  surname: Gersten
  fullname: Gersten, Merril
  organization: Department of Bioengineering, University of California, 9500 Gilman Drive MC 0412, San Diego, La Jolla, CA 92093, USA
– sequence: 9
  givenname: Aneesh K
  surname: Mehta
  fullname: Mehta, Aneesh K
  organization: Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, 1648 Pierce Drive NE, Atlanta, GA 30307, USA
– sequence: 10
  givenname: Renaud
  surname: Gaujoux
  fullname: Gaujoux, Renaud
  organization: Department of Immunology, Faculty of Medicine, Technion, 1 Efron Street, Haifa 3109601, Israel
– sequence: 11
  givenname: Gui-Mei
  surname: Li
  fullname: Li, Gui-Mei
  organization: Department of Microbiology and Immunology, Emory University, 1510 Clifton Road, Atlanta, GA 30322, USA; Emory Vaccine Center, Yerkes National Primate Research Center, 954 Gatewood Road, Atlanta, GA 30329, USA
– sequence: 12
  givenname: Shakti
  surname: Gupta
  fullname: Gupta, Shakti
  organization: Department of Bioengineering, University of California, 9500 Gilman Drive MC 0412, San Diego, La Jolla, CA 92093, USA
– sequence: 13
  givenname: Rafi
  surname: Ahmed
  fullname: Ahmed, Rafi
  organization: Department of Microbiology and Immunology, Emory University, 1510 Clifton Road, Atlanta, GA 30322, USA; Emory Vaccine Center, Yerkes National Primate Research Center, 954 Gatewood Road, Atlanta, GA 30329, USA
– sequence: 14
  givenname: Mark J
  surname: Mulligan
  fullname: Mulligan, Mark J
  organization: Hope Clinic of Emory University, 500 Irvin Court/Suite 200, Atlanta, GA 30030, USA
– sequence: 15
  givenname: Shai
  surname: Shen-Orr
  fullname: Shen-Orr, Shai
  organization: Department of Immunology, Faculty of Medicine, Technion, 1 Efron Street, Haifa 3109601, Israel
– sequence: 16
  givenname: Bonnie B
  surname: Blomberg
  fullname: Blomberg, Bonnie B
  organization: Department of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL 33136, USA
– sequence: 17
  givenname: Shankar
  surname: Subramaniam
  fullname: Subramaniam, Shankar
  email: shankar@ucsd.edu
  organization: Department of Bioengineering, University of California, 9500 Gilman Drive MC 0412, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA 92093, USA; Department of Nanoengineering, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA 92093, USA; Department of Computer Science and Engineering, University of California, 9500 Gilman Drive, San Diego, La Jolla, CA 92093, USA. Electronic address: shankar@ucsd.edu
– sequence: 18
  givenname: Bali
  surname: Pulendran
  fullname: Pulendran, Bali
  email: bpulend@emory.edu
  organization: Department of Pathology, School of Medicine, Emory University, 1648 Pierce Drive NE, Atlanta, GA 30307, USA; Emory Vaccine Center, Yerkes National Primate Research Center, 954 Gatewood Road, Atlanta, GA 30329, USA. Electronic address: bpulend@emory.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26682988$$D View this record in MEDLINE/PubMed
BookMark eNo1kM1KAzEUhYMo1lbfQOQu3XTMTWemybL4W6goVgVXJTNzqymZpCYzhfoIPrWD1s09i_Pxwbl9tu-8I8ZOkSfIMb9YJaauW2cSwTFLEBOOYo8dIVfjYYqS91g_xhXnmGaKH7KeyHMplJRH7Hu-jQ3VESZO2200EfwSpr-yZguNh6lb2pbcl4ZXXZbG6cZ4B7oMPka4b21j1pbgjXSIoF0FxsGV2VCIBI9-3dpfPsITbUjbCPMPHaiCe2-p7MoAc_PeOdtA8ZgdLDuETnY5YC8318-Xd8PZw-30cjIblplImyGi0CofKVQjKiriPJOqkKPuIMkKSUnipAvky6zqVhaYSlkWWAmu8jIVJAbs_M-7Dv6zpdgsahNLslY78m1c4Djj6SjPM9GhZzu0LWqqFutgah22i___iR_AinZ7
CitedBy_id crossref_primary_10_1016_j_ehb_2023_101319
crossref_primary_10_1155_2022_8637545
crossref_primary_10_1002_VIW_20240017
crossref_primary_10_1186_s12979_018_0137_4
crossref_primary_10_1038_s41541_022_00583_w
crossref_primary_10_1111_cei_12829
crossref_primary_10_1172_JCI148542
crossref_primary_10_3389_fimmu_2019_00874
crossref_primary_10_1038_s41541_020_0177_6
crossref_primary_10_3389_fimmu_2017_00445
crossref_primary_10_3390_nu15081955
crossref_primary_10_1371_journal_ppat_1007290
crossref_primary_10_1111_imm_13012
crossref_primary_10_1186_s12967_017_1252_2
crossref_primary_10_3389_fimmu_2024_1412732
crossref_primary_10_1016_j_vaccine_2025_127677
crossref_primary_10_7717_peerj_18856
crossref_primary_10_3389_fgene_2019_01120
crossref_primary_10_3389_fimmu_2019_00180
crossref_primary_10_1038_s41598_020_60213_0
crossref_primary_10_1126_sciimmunol_aal4656
crossref_primary_10_3389_fvets_2022_922992
crossref_primary_10_4049_jimmunol_1900033
crossref_primary_10_3389_fimmu_2019_02247
crossref_primary_10_1097_QAD_0000000000001821
crossref_primary_10_3390_ijms26083765
crossref_primary_10_4049_jimmunol_1900922
crossref_primary_10_1371_journal_pone_0306953
crossref_primary_10_1038_s41590_024_02036_z
crossref_primary_10_1182_blood_2018_02_791509
crossref_primary_10_1038_s41467_023_37128_1
crossref_primary_10_3389_fcimb_2019_00107
crossref_primary_10_3389_fimmu_2021_639358
crossref_primary_10_1038_s41598_021_99870_0
crossref_primary_10_12688_wellcomeopenres_11300_3
crossref_primary_10_12688_wellcomeopenres_11300_2
crossref_primary_10_12688_wellcomeopenres_11300_1
crossref_primary_10_1080_2162402X_2016_1249560
crossref_primary_10_1371_journal_ppat_1005892
crossref_primary_10_1093_cid_ciy818
crossref_primary_10_1038_s41597_019_0213_4
crossref_primary_10_1111_nyas_14975
crossref_primary_10_1186_s12979_018_0124_9
crossref_primary_10_1038_s41573_021_00163_y
crossref_primary_10_1371_journal_pone_0169271
crossref_primary_10_3389_fimmu_2018_00301
crossref_primary_10_1186_s12979_023_00334_y
crossref_primary_10_3389_fimmu_2017_01083
crossref_primary_10_1371_journal_pone_0221143
crossref_primary_10_7554_eLife_55678
crossref_primary_10_1126_science_aay4014
crossref_primary_10_1038_s41564_022_01281_y
crossref_primary_10_1128_JVI_01001_16
crossref_primary_10_1038_s41598_019_38906_y
crossref_primary_10_1016_j_cell_2017_04_026
crossref_primary_10_1016_j_chom_2020_06_014
crossref_primary_10_1073_pnas_1822046116
crossref_primary_10_7554_eLife_70554
crossref_primary_10_1007_s00281_020_00821_0
crossref_primary_10_1038_s41467_024_46560_w
crossref_primary_10_3389_fimmu_2020_583019
crossref_primary_10_1016_j_cellimm_2023_104777
crossref_primary_10_3390_ijms23179880
crossref_primary_10_1016_j_exger_2018_01_019
crossref_primary_10_1002_eji_201546178
crossref_primary_10_1016_j_bbi_2022_03_019
crossref_primary_10_1097_HC9_0000000000000273
crossref_primary_10_1038_s41597_022_01714_7
crossref_primary_10_1126_scitranslmed_aay8924
crossref_primary_10_1093_infdis_jiae505
crossref_primary_10_1038_s41541_023_00702_1
crossref_primary_10_3390_vaccines13070718
crossref_primary_10_1016_j_actbio_2019_04_033
crossref_primary_10_1146_annurev_immunol_042617_053035
crossref_primary_10_1371_journal_pone_0266719
crossref_primary_10_3389_fimmu_2017_00896
crossref_primary_10_1038_s41541_025_01072_6
crossref_primary_10_1038_s42003_020_01296_3
crossref_primary_10_1016_j_it_2023_06_005
crossref_primary_10_1016_j_micinf_2024_105318
crossref_primary_10_1126_scitranslmed_aaj1701
crossref_primary_10_1016_j_vaccine_2018_09_021
crossref_primary_10_1186_s12979_023_00408_x
crossref_primary_10_1038_s41591_020_0769_8
crossref_primary_10_1111_bjh_16497
crossref_primary_10_1155_2022_7561661
crossref_primary_10_3389_fcimb_2024_1243586
crossref_primary_10_1371_journal_pone_0191812
crossref_primary_10_1007_s44370_025_00027_8
crossref_primary_10_1016_j_isci_2025_113475
crossref_primary_10_1038_s41541_022_00573_y
crossref_primary_10_1007_s00011_021_01510_w
crossref_primary_10_1126_sciimmunol_abk0018
crossref_primary_10_1016_j_anai_2020_04_008
crossref_primary_10_1016_j_vaccine_2019_10_091
crossref_primary_10_1038_ncomms12614
crossref_primary_10_1038_s41590_022_01329_5
crossref_primary_10_3390_microorganisms7030079
crossref_primary_10_1038_nri_2016_125
crossref_primary_10_1016_j_cell_2021_05_039
crossref_primary_10_1189_jlb_5MR0617_216R
crossref_primary_10_1038_s41577_021_00554_7
crossref_primary_10_15252_msb_20209888
crossref_primary_10_3389_fimmu_2017_01962
crossref_primary_10_1016_j_smim_2020_101422
crossref_primary_10_3389_fimmu_2024_1358477
crossref_primary_10_1016_j_smim_2020_101420
crossref_primary_10_1128_CMR_00084_18
crossref_primary_10_4049_jimmunol_1601425
crossref_primary_10_3390_vaccines9050506
crossref_primary_10_1038_s41467_023_43420_x
crossref_primary_10_3389_fimmu_2023_1283343
crossref_primary_10_3390_vaccines9060579
crossref_primary_10_1089_dna_2020_5942
crossref_primary_10_1126_scitranslmed_aay8618
crossref_primary_10_3390_ijms23179797
crossref_primary_10_1038_s42003_020_01543_7
crossref_primary_10_1016_j_immuni_2017_03_010
crossref_primary_10_1007_s40264_018_0657_z
crossref_primary_10_1038_s41590_021_01058_1
crossref_primary_10_1186_s12979_023_00348_6
crossref_primary_10_1016_j_iotech_2025_101054
crossref_primary_10_1016_j_molmed_2022_09_008
crossref_primary_10_1128_jvi_00247_25
crossref_primary_10_1038_s41591_019_0381_y
crossref_primary_10_1093_cid_cix429
crossref_primary_10_7554_eLife_52473
crossref_primary_10_1093_intimm_dxac064
crossref_primary_10_1186_s12979_022_00301_z
crossref_primary_10_1016_j_immuni_2015_11_018
crossref_primary_10_1038_s41590_022_01328_6
crossref_primary_10_1111_1751_7915_12835
crossref_primary_10_3390_ijms25137095
crossref_primary_10_1111_acel_13682
crossref_primary_10_1186_s12979_022_00286_9
crossref_primary_10_1016_j_molimm_2024_03_005
crossref_primary_10_4049_jimmunol_1601119
crossref_primary_10_12688_f1000research_18533_1
crossref_primary_10_3390_ijms21228524
crossref_primary_10_3390_vaccines9010059
crossref_primary_10_3389_fimmu_2021_668045
crossref_primary_10_1080_21645515_2023_2267295
crossref_primary_10_3389_fimmu_2017_00943
crossref_primary_10_1016_j_coche_2020_100660
crossref_primary_10_3390_v13091871
crossref_primary_10_1016_j_tim_2022_01_007
crossref_primary_10_1016_j_cell_2018_06_045
crossref_primary_10_1080_1040841X_2025_2480230
crossref_primary_10_1128_JVI_00797_19
crossref_primary_10_3389_fimmu_2022_848961
crossref_primary_10_1097_QAI_0000000000002860
crossref_primary_10_1038_s41598_023_34163_2
crossref_primary_10_1097_QAI_0000000000002864
crossref_primary_10_3390_vaccines9111340
crossref_primary_10_1038_s41541_019_0151_3
crossref_primary_10_3390_vaccines10101752
crossref_primary_10_1038_s41467_022_34487_z
crossref_primary_10_3389_fimmu_2024_1282754
crossref_primary_10_1016_j_ebiom_2025_105744
crossref_primary_10_3389_fimmu_2019_01087
crossref_primary_10_1186_s12979_020_00210_z
crossref_primary_10_1542_peds_2018_1489
crossref_primary_10_1016_j_it_2016_05_005
crossref_primary_10_3389_fimmu_2019_02616
crossref_primary_10_1038_s41541_020_0175_8
crossref_primary_10_1038_s41577_023_00941_2
crossref_primary_10_3389_fimmu_2020_582201
crossref_primary_10_1016_j_jaci_2020_03_017
crossref_primary_10_1371_journal_ppat_1012557
crossref_primary_10_1038_s41541_024_01000_0
crossref_primary_10_1080_14760584_2022_2045198
crossref_primary_10_1111_nyas_14235
crossref_primary_10_3390_vaccines12020121
crossref_primary_10_1016_j_jmb_2024_168522
crossref_primary_10_1073_pnas_1705065114
crossref_primary_10_1093_cei_uxaf034
crossref_primary_10_1016_j_celrep_2024_114370
crossref_primary_10_3390_vaccines9020067
crossref_primary_10_1016_j_immuni_2023_03_001
crossref_primary_10_1038_s41598_018_21222_2
crossref_primary_10_1080_1744666X_2022_2106217
crossref_primary_10_3390_v13050948
crossref_primary_10_1542_peds_2021_052061
crossref_primary_10_1038_s41514_017_0020_0
crossref_primary_10_1038_s41541_018_0078_0
crossref_primary_10_3390_v14030652
crossref_primary_10_1038_s41392_024_02002_z
crossref_primary_10_1155_2017_3017632
crossref_primary_10_3390_biomedicines11113002
crossref_primary_10_1038_s41541_017_0027_3
crossref_primary_10_1016_j_cell_2019_08_010
crossref_primary_10_1146_annurev_immunol_090122_042631
crossref_primary_10_1128_jvi_01863_24
crossref_primary_10_1038_s41590_024_02040_3
crossref_primary_10_7774_cevr_2024_13_4_271
crossref_primary_10_1016_j_coi_2020_05_001
crossref_primary_10_1371_journal_ppat_1009363
crossref_primary_10_1038_s41541_023_00682_2
crossref_primary_10_1038_s41590_018_0231_y
crossref_primary_10_3389_fimmu_2022_889945
crossref_primary_10_1016_j_medj_2020_12_006
crossref_primary_10_1146_annurev_immunol_042617_053206
crossref_primary_10_3389_fimmu_2021_643255
crossref_primary_10_1016_j_immuni_2024_04_009
crossref_primary_10_1016_j_vaccine_2017_03_099
crossref_primary_10_3390_cells13060526
crossref_primary_10_1016_j_smim_2023_101801
crossref_primary_10_1088_1742_5468_2017_1_013401
crossref_primary_10_1038_s41586_021_03791_x
crossref_primary_10_1126_science_aau6975
crossref_primary_10_1016_j_xcrm_2025_102050
crossref_primary_10_1287_inte_2016_0862
crossref_primary_10_1038_s41598_017_17735_x
crossref_primary_10_3389_fimmu_2018_03175
crossref_primary_10_1586_14760584_2016_1168701
crossref_primary_10_3390_idr14050076
ContentType Journal Article
Copyright Copyright © 2015 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2015 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.immuni.2015.11.012
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1097-4180
EndPage 1198
ExternalDocumentID 26682988
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: R37 AG023717
– fundername: NIAID NIH HHS
  grantid: U19 AI057266
– fundername: NIAID NIH HHS
  grantid: P30 AI050409
– fundername: NIAID NIH HHS
  grantid: U54 AI057157
– fundername: NIAID NIH HHS
  grantid: R37AI48638
– fundername: NIAID NIH HHS
  grantid: U19AI057266
– fundername: NIAID NIH HHS
  grantid: U19 AI090023
– fundername: NIDDK NIH HHS
  grantid: R37DK057665
– fundername: NIAID NIH HHS
  grantid: U19AI090023
– fundername: NIAID NIH HHS
  grantid: HHSN272201400004C
GroupedDBID ---
--K
-DZ
0R~
1RT
1~5
2WC
4.4
457
4G.
53G
5GY
62-
7-5
8FE
8FH
AAEDT
AAEDW
AAKRW
AALRI
AAMRU
AAVLU
AAXUO
AAYWO
ABDGV
ABJNI
ABMAC
ABOCM
ACGFO
ACGFS
ACIWK
ACPRK
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADVLN
AEFWE
AENEX
AEUPX
AEXQZ
AFPUW
AFRAH
AFTJW
AGCQF
AGGSO
AGHFR
AGKMS
AHHHB
AHMBA
AIGII
AITUG
AKAPO
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BKEYQ
BPHCQ
BVXVI
C45
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EFKBS
EIF
EJD
F5P
FCP
FDB
FIRID
IH2
IHE
IXB
J1W
JIG
LK8
LX5
M3Z
M41
N9A
NPM
O-L
O9-
OK1
OVD
P2P
PQQKQ
PROAC
RIG
ROL
RPZ
SCP
SES
SSZ
TEORI
TR2
7X8
ID FETCH-LOGICAL-c524t-112a9639193ebde00589b8389b1e8d1e98e0eab10f5d682b1488cb1d2096c42e2
IEDL.DBID 7X8
ISICitedReferencesCount 244
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000366846600021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Sat Sep 27 19:24:54 EDT 2025
Mon Jul 21 05:56:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Copyright © 2015 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c524t-112a9639193ebde00589b8389b1e8d1e98e0eab10f5d682b1488cb1d2096c42e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.cell.com/article/S1074761315004902/pdf
PMID 26682988
PQID 1750436652
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_1750436652
pubmed_primary_26682988
PublicationCentury 2000
PublicationDate 2015-12-15
PublicationDateYYYYMMDD 2015-12-15
PublicationDate_xml – month: 12
  year: 2015
  text: 2015-12-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Immunity (Cambridge, Mass.)
PublicationTitleAlternate Immunity
PublicationYear 2015
SSID ssj0014590
Score 2.6084363
Snippet Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1186
SubjectTerms Adult
Aged
Antibodies, Viral - blood
Antibodies, Viral - genetics
Female
Flow Cytometry
Humans
Influenza Vaccines - immunology
Influenza, Human - prevention & control
Male
Middle Aged
Oligonucleotide Array Sequence Analysis
Seasons
Systems Analysis
Transcriptome - immunology
Title Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures
URI https://www.ncbi.nlm.nih.gov/pubmed/26682988
https://www.proquest.com/docview/1750436652
Volume 43
WOSCitedRecordID wos000366846600021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LSgMxFA1qVdz4qK_64gpuRzvvzEpELRacUnyUuip53JFuZqozFuon-NUmmRm7EgQ32QXCzU1ykntyDiFniQy1pAi32sINLC8J0GIsUblMXY5hxFAa_5TBfdjr0eEw6lcPbnlFq6z3RLNRy0zoN_ILW-uQu0HgO5eTN0u7RunqamWhsUgaroIyOqvD4byK4PlRu_4uZzhdY_PnQhO6_HOt3al9KH8DluaA6Wz8d2ibZL2ClnBV5sIWWcC0SVZKs8lZk6zGVRl9m3xVOuVQS5JAlkDXjLqYQZFBt7Qu-WQwYEL1MdMHzBypEFccRHhRqyQHlkoYp3BjCB4I_R9HsBwecKpwaA5aFRolxLUVLzyOX0tF0XyHPHdun67vrMqUwRK-4xWWwmdMLdpIAT_kEo0tIacK9nAbqbQxothGxu124suAOlxdt6jgtnTUXUl4Djq7ZCnNUtwnINxIm__4mHD00PWYDFjI7IRyX1LPES1yWsd7pJJeVzJYitlHPppHvEX2ykkbTUp1jpFCHNSJKD34Q-9DsqZzQdNTbP-INBIVEzwmy2JajPP3E5NNqu31428cldlO
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systems+Analysis+of+Immunity+to+Influenza+Vaccination+across+Multiple+Years+and+in+Diverse+Populations+Reveals+Shared+Molecular+Signatures&rft.jtitle=Immunity+%28Cambridge%2C+Mass.%29&rft.au=Nakaya%2C+Helder+I&rft.au=Hagan%2C+Thomas&rft.au=Duraisingham%2C+Sai+S&rft.au=Lee%2C+Eva+K&rft.date=2015-12-15&rft.eissn=1097-4180&rft.volume=43&rft.issue=6&rft.spage=1186&rft_id=info:doi/10.1016%2Fj.immuni.2015.11.012&rft_id=info%3Apmid%2F26682988&rft_id=info%3Apmid%2F26682988&rft.externalDocID=26682988